Metraipolis › archive › dc_016abc70c321

Optimizing Infusion Center Efficiency in Multiple Sclerosis: A Nursing Multicenter Survey on Organizational Impact of Ublituximab — Europe PMC PMID:42512610

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/42512610
DOI: 10.3390/healthcare14142094
License (as archived): solo-consultazione
Archived: 2026-10-08T02:32:23.152Z
SHA-256 of the archived text: 847bc23b58fb8ff69c1b88b4300d5e05d2920972436f678ee69d7c5717a7f3d9
Stable URL of this page: https://metraipolis.com/documento/dc_016abc70c321

How to cite

Optimizing Infusion Center Efficiency in Multiple Sclerosis: A Nursing Multicenter Survey on Organizational Impact of Ublituximab — Europe PMC PMID:42512610 — Europe PMC (en), https://europepmc.org/article/MED/42512610 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_016abc70c321 (Metraipolis archive dc_016abc70c321, sha256 847bc23b58fb8ff69c1b88b4300d5e05d2920972436f678ee69d7c5717a7f3d9)

BibTeX

@misc{dc016abc70c321,
  title = {Optimizing Infusion Center Efficiency in Multiple Sclerosis: A Nursing Multicenter Survey on Organizational Impact of Ublituximab — Europe PMC PMID:42512610},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42512610},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_016abc70c321; sha256 847bc23b58fb8ff69c1b88b4300d5e05d2920972436f678ee69d7c5717a7f3d9},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42512610. Agents can read the archived copy with the MCP tool read_document.